XIth Eurasian Hematology-Oncology Congress - EHOC 2020
ASCT in MCL: Are There Patients Who Don't Benefit From ASCT? Does Pre-Transplant MRD Predict Survival Outcomes? Can Novel Agents Eliminate the Need for ASCT?
Comments 0
Login to view comments.
Click here to Login
